LATEST

Is favorable-risk GG2 prostate Ca suitable for active surveillance?"The management of prostate cancer always requires caution to safeguard against avoidable risks from both the treatment and the monitoring protocol," writes Badar M. Mian, MD.
How to manage your reputation, recruit patients onlineIn today’s digital world, having an active professional presence online has become a must.
Tax law may threaten Medicare, provider pay"Perhaps the biggest Medicare reform concern for urologists is the potential for provider reimbursements cuts, a threat that has continued to loom over the health care community for some time," writes the AACU's Ally Lopshire.
How important is urology/gynecology collaboration?"It’s absolutely important. Because we have so much overlap in our patient population, our patients are best served by us working together," says one urologist.
5 years and 50 blogs later: Big lessons from the real worldUrologist Henry Rosevear, MD, reflects on the three lessons he's learned in 5 years of practicing urology.
The switch to OTC: Are urologic drugs next?Switching a medication from prescription to over-the-counter status comes with challenges and risks, and is not always successful. In this interview, Roger Dmochowski, MD, discusses the pros and cons of OTC medications and explains the hurdles facing potential OTC products for urologic conditions.
Medical field no stranger to sexual harassmentIn 2017, a flood of accusations against high-profile men in positions of power in Hollywood, the U.S. government, and the national media have focused the nation’s attention on sexual harassment and its consequences. The medical workplace is not immune from harassment, and the national conversation presents an opportunity for health care businesses to review their risk, policies, and prevention strategies.
How to form a student loan repayment strategyForming a student loan repayment strategy is not a one-size-fits-all process. What works well for a friend or colleague may not be an effective strategy for you.
Genetic testing for prostate Ca: What the experts sayA recently published statement provides an evidence-based, consensus-driven framework on the role of genetic testing for determining prostate cancer risk, screening, and management.
Liquid biopsy tests for prostate Ca show low congruenceThe findings “[raise] the specter that patients could potentially receive different treatments depending on the cell-free DNA platform,” authors of a recent research letter write.

Poll